目的:研究卵胞浆内精子注射(ICSI)周期卵母细胞滑面内质网(sER)聚集对早期胚胎体外发育及妊娠结局的影响并分析其原因。方法:99例患者ICSI治疗107个周期,于HCG日测定血清激素E2、P、LH浓度以及子宫内膜厚度。根据所获MⅡ期卵母细胞是否...目的:研究卵胞浆内精子注射(ICSI)周期卵母细胞滑面内质网(sER)聚集对早期胚胎体外发育及妊娠结局的影响并分析其原因。方法:99例患者ICSI治疗107个周期,于HCG日测定血清激素E2、P、LH浓度以及子宫内膜厚度。根据所获MⅡ期卵母细胞是否出现sER聚集分为A、B两组,A组为所获MⅡ期卵母细胞均未出现sER聚集周期共90例;B组为有至少一枚MⅡ期卵母细胞出现sER聚集周期,共17例。比较A、B两组HCG日E2、P、LH水平、子宫内膜厚度,及治疗周期数、年龄、病程、Gn总量、Gn天数、获卵数、受精率、可用胚胎率、优质胚胎率、移植胚胎数、周期临床妊娠率、种植率、流产率和原发、继发不孕患者比例的差异。并且对比B组sER聚集阳性[sER(+)]与sER聚集阴性[sER(-)]卵母细胞的受精率、可用胚胎率和优质胚胎率。结果:B组HCG日E2水平明显高于A组(P<0.05,3141.18±604.47 vs 2635.12±825.46),而两组间P和LH水平以及子宫内膜厚度均无显著差异(P>0.05)。B组优质胚胎率显著低于A组(P<0.05,47.83%vs 57.67%),而B组Gn天数(P<0.01,13.35±1.66 vs 11.83±2.4)和流产率(P<0.05,100%vs 17.86%)均明显高于A组,两组在年龄、治疗周期数、病程、Gn总量、获卵数、受精率、可用胚胎率、移植胚胎数、临床妊娠率、种植率以及原发、继发不孕患者比例等各方面均无显著差异(P>0.05)。B组sER(+)卵母细胞的优质胚胎率显著低于sER-卵母细胞(P<0.01,20.69%vs 52.9%),而受精率和可用胚胎率无显著性差异(P>0.05)。结论:ICSI周期卵母细胞sER聚集对早期胚胎体外发育及妊娠结局均有不良影响,sER聚集可能与HCG日高E2水平及长时间Gn刺激有关。展开更多
From January 2001 to January 2002, 50 patients of candidal vaginitis were treated by Kushen powder (KSP,苦参散) combined with Canesten as the treatment group, and controlled by a control group including another 50 pat...From January 2001 to January 2002, 50 patients of candidal vaginitis were treated by Kushen powder (KSP,苦参散) combined with Canesten as the treatment group, and controlled by a control group including another 50 patients treated with Canesten alone. The therapeutic results were satisfactory and reported as follows.展开更多
Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo tra...Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo transfer(IVF-ET) were randomized equally into a treated group and a control group. Further,20 patients who received IVF-ET due to oviduct factors were enrolled into a non-endometriosis group. The dosage of gonadotrophic hormone used,the number of ova attained,fertilization rate and clinical pregnancy ra...展开更多
Objective： To observe the clinical efficacy of Quyu Jiedu Recipe （祛瘀解毒方,QJR） in treating endometriosis （EM）, and to explore the levels of vascular endothelial growth factor （VEGF） and cell proliferative nu...Objective： To observe the clinical efficacy of Quyu Jiedu Recipe （祛瘀解毒方,QJR） in treating endometriosis （EM）, and to explore the levels of vascular endothelial growth factor （VEGF） and cell proliferative nucleoprotein antigen （Ki-67）, their changes before and after treatment and the clinical significance in the trial. Methods： Fifty patients of EM were randomly assigned to two groups. The 26 patients in the Q JR group were treated with Q JR, and the 24 patients in the gestrinone （GT） group with gestrinone. Besides, a normal control group with 20 healthy women was set up. The therapeutic effects in the two treated groups were compared. Expressions of VEGF and Ki-67 in eutopic endometrium of all subjects （with both patients and healthy women at the median secretive phase） were determined with immunohistochemical stain before treatment, and the determination in the two treated groups was repeated after 3-month treatment in the same phase. Results： Before treatment, the VEGF and Ki-67 expression positive rates and their mean optic density （MOD） were higher in patients than in healthy women （P〈0.05）. After treatment, the positive rate and MOD of VEGF expression lowered significantly than before treatment （P〈0.05）, but those of Ki-67 changed insignificantly, and comparison between the two treated groups showed no significant difference （P〉0.05）. Conclusion： Q JR could markedly improve the symptoms of menorrhagia and menstrual disorder, and its mechanism might be related with the lowering of eutopic endometrial VEGF expression. VEGF and Ki-67 show a high expression in eutopic endometrium of patients with EM.展开更多
文摘目的:研究卵胞浆内精子注射(ICSI)周期卵母细胞滑面内质网(sER)聚集对早期胚胎体外发育及妊娠结局的影响并分析其原因。方法:99例患者ICSI治疗107个周期,于HCG日测定血清激素E2、P、LH浓度以及子宫内膜厚度。根据所获MⅡ期卵母细胞是否出现sER聚集分为A、B两组,A组为所获MⅡ期卵母细胞均未出现sER聚集周期共90例;B组为有至少一枚MⅡ期卵母细胞出现sER聚集周期,共17例。比较A、B两组HCG日E2、P、LH水平、子宫内膜厚度,及治疗周期数、年龄、病程、Gn总量、Gn天数、获卵数、受精率、可用胚胎率、优质胚胎率、移植胚胎数、周期临床妊娠率、种植率、流产率和原发、继发不孕患者比例的差异。并且对比B组sER聚集阳性[sER(+)]与sER聚集阴性[sER(-)]卵母细胞的受精率、可用胚胎率和优质胚胎率。结果:B组HCG日E2水平明显高于A组(P<0.05,3141.18±604.47 vs 2635.12±825.46),而两组间P和LH水平以及子宫内膜厚度均无显著差异(P>0.05)。B组优质胚胎率显著低于A组(P<0.05,47.83%vs 57.67%),而B组Gn天数(P<0.01,13.35±1.66 vs 11.83±2.4)和流产率(P<0.05,100%vs 17.86%)均明显高于A组,两组在年龄、治疗周期数、病程、Gn总量、获卵数、受精率、可用胚胎率、移植胚胎数、临床妊娠率、种植率以及原发、继发不孕患者比例等各方面均无显著差异(P>0.05)。B组sER(+)卵母细胞的优质胚胎率显著低于sER-卵母细胞(P<0.01,20.69%vs 52.9%),而受精率和可用胚胎率无显著性差异(P>0.05)。结论:ICSI周期卵母细胞sER聚集对早期胚胎体外发育及妊娠结局均有不良影响,sER聚集可能与HCG日高E2水平及长时间Gn刺激有关。
文摘From January 2001 to January 2002, 50 patients of candidal vaginitis were treated by Kushen powder (KSP,苦参散) combined with Canesten as the treatment group, and controlled by a control group including another 50 patients treated with Canesten alone. The therapeutic results were satisfactory and reported as follows.
基金Supported by the National Natural Science Foundation of China(No.30672706)
文摘Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo transfer(IVF-ET) were randomized equally into a treated group and a control group. Further,20 patients who received IVF-ET due to oviduct factors were enrolled into a non-endometriosis group. The dosage of gonadotrophic hormone used,the number of ova attained,fertilization rate and clinical pregnancy ra...
基金Supported by Research Projects of Medical Science and Hygiene of Shandong Province 1999 (No 42)
文摘Objective： To observe the clinical efficacy of Quyu Jiedu Recipe （祛瘀解毒方,QJR） in treating endometriosis （EM）, and to explore the levels of vascular endothelial growth factor （VEGF） and cell proliferative nucleoprotein antigen （Ki-67）, their changes before and after treatment and the clinical significance in the trial. Methods： Fifty patients of EM were randomly assigned to two groups. The 26 patients in the Q JR group were treated with Q JR, and the 24 patients in the gestrinone （GT） group with gestrinone. Besides, a normal control group with 20 healthy women was set up. The therapeutic effects in the two treated groups were compared. Expressions of VEGF and Ki-67 in eutopic endometrium of all subjects （with both patients and healthy women at the median secretive phase） were determined with immunohistochemical stain before treatment, and the determination in the two treated groups was repeated after 3-month treatment in the same phase. Results： Before treatment, the VEGF and Ki-67 expression positive rates and their mean optic density （MOD） were higher in patients than in healthy women （P〈0.05）. After treatment, the positive rate and MOD of VEGF expression lowered significantly than before treatment （P〈0.05）, but those of Ki-67 changed insignificantly, and comparison between the two treated groups showed no significant difference （P〉0.05）. Conclusion： Q JR could markedly improve the symptoms of menorrhagia and menstrual disorder, and its mechanism might be related with the lowering of eutopic endometrial VEGF expression. VEGF and Ki-67 show a high expression in eutopic endometrium of patients with EM.
